Nonsurgical management of Peyronie’s disease
The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Abstract
Peyronie's disease is not a rare disorder, and it can be devastating to the affected man. Although the gold-standard treatment of Peyronie's disease is surgery in the stable phase, nonoperative management is preferred by some men and is the only treatment option in the acute phase of the disease, when surgery is contraindicated. No oral or topical therapy has been shown to be efficacious when administered alone, but some evidence supports their use as part of a combination therapy regimen. Intralesional therapies, particularly collagenase clostridium histolyticum (CCH), have shown promise. Mechanical therapies can provide benefit when applied for prolonged periods of time, improving penile curvature, indentation, and even restoring length. Regardless of the modality chosen, patient counselling is paramount, as recovery of the penis to its predisease state is highly unlikely. Thus, although many options exist for nonsurgical management of Peyronie's disease, surgery remains the best option for men who desire the most reliable and rapid pathway to a functionally straight, erect penis. The goal of nonsurgical therapy should be a scientifically feasible, safe approach to prevent the progression of, or reduce, deformity and improve sexual function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Common treatment methods for penile induration include medication therapy, injection therapy, and surgical treatment.133,147,148”
From Research advances in Peyronie's disease: a comprehensive review on genomics, pathways, phenotypic manifestation, and therapeutic targets. (2024) · cites this paper as [147]
Citations
Cites
1 retracted
Safarinejad, M. R., Asgari, M. A., Hosseini, S. Y., & Dadkhah, F. (2010) · BJU International · doi:10.1111/j.1464-410x.2009.09041.x · Cited by 77
RetractedChamberlain, G., Fox, J., Ashton, B., & Middleton, J. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0197 · Cited by 2,381
Some recent advances in the chemistry and biology of transforming growth factor-beta.
Sporn, M. B., Roberts, A. B., Wakefield, L. M., & de Crombrugghe, B. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.3.1039 · Cited by 1,279
Keloid Pathogenesis and Treatment
Al-Attar, A., Mess, S., Thomassen, J. M., Kauffman, C. L., & Davison, S. P. (2006) · Plastic and Reconstructive Surgery · doi:10.1097/01.prs.0000195073.73580.46 · Cited by 553
Gelbard, M., Goldstein, I., Hellstrom, W. J. G., McMahon, C. G., Smith, T., Tursi, J., Jones, N., Kaufman, G. J., & Carson, C. C. (2013) · Journal of Urology · doi:10.1016/j.juro.2013.01.087 · Cited by 466
The prevalence of Peyronie's disease: results of a large survey
Schwarzer, U., Sommer, F., Klotz, T., Braun, M., Reifenrath, B., & Engelmann, U. (2001) · BJU International · doi:10.1046/j.1464-4096.2001.02436.x · Cited by 440
An Analysis of the Natural History of Peyronie’s Disease
Mulhall, J. P., Schiff, J., & Guhring, P. (2006) · Journal of Urology · doi:10.1016/s0022-5347(06)00270-9 · Cited by 417
Peyronie’s Disease: AUA Guideline
Nehra, A., Alterowitz, R., Culkin, D. J., Faraday, M. M., Hakim, L. S., Heidelbaugh, J. J., Khera, M., Kirkby, E., McVary, K. T., Miner, M. M., et al. (2015) · Journal of Urology · doi:10.1016/j.juro.2015.05.098 · Cited by 416
Mechanism of Action of Colchicine in the Treatment of Gout
Dalbeth, N., Lauterio, T. J., & Wolfe, H. R. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.07.017 · Cited by 416
MULHALL, J. P., CREECH, S. D., BOORJIAN, S. A., GHALY, S., KIM, E. D., MOTY, A., DAVIS, R., & HELLSTROM, W. (2004) · Journal of Urology · doi:10.1097/01.ju.0000127744.18878.f1 · Cited by 385
Research works printed but not linked: 3
- de la Peyronie, F. G. Sur quelques obstacles qui s’opposent a l’ejaculation naturelle de la semence [French]. Mém. Acad. R. Chir. 1, 425–434 (1743).
- Pryor, J. P., & Farrell, C. F. Controlled clinic trial of vitamin E in Peyronie’s disease. Prog. Reprod. Biol. 9, 41–45 (1983).
- Jalkut, M., Gonzalez-Cadavid, N. & Rajfer, J. Peyronie’s fisease: a review. Rev. Urol. 5, 142–148 (2003).
Cited by
Peyronie’s disease: Contemporary evaluation and management
Ziegelmann, M. J., Bajic, P., & Levine, L. A. (2020) · International Journal of Urology · doi:10.1111/iju.14230 · Cited by 86
Self-citationMolecular Mechanisms and Current Pharmacotherapy of Peyronie’s Disease: A Review
Zhang, F., Qin, F., & Yuan, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.643641 · Cited by 29
Farrell, M. R., Abdelsayed, G. A., Ziegelmann, M. J., & Levine, L. A. (2019) · Urology · doi:10.1016/j.urology.2019.03.008 · Cited by 25
“Treatment options including oral and topical therapy, intralesional injections, and penile traction therapy have been studied with varying levels of clinical evidence, and efficacy is highly variable as well.(3) However, in patients with bothersome penile curvature, surgical straightening with penile plication or inci…”
BackgroundSelf-citationLevine, L. A., Ziegelmann, M., & Farrell, M. R. (2019) · Asian Journal of Andrology · doi:10.4103/aja.aja_81_19 · Cited by 25
Self-citationPyrgidis, N., Yafi, F. A., Sokolakis, I., Dimitriadis, F., Mykoniatis, I., Russo, G. I., Verze, P., & Hatzichristodoulou, G. (2022) · European Urology Focus · doi:10.1016/j.euf.2021.12.003 · Cited by 19
Metadata
- Authors
- Tsambarlis, P., & Levine, L. A.
- Affiliations
- Rush University Medical Center (US)
- Corresponding author
- Levine, Laurence A.
- Venue
- Nature Reviews Urology
- Published
- 2018-11-05
- Volume
- 16
- Issue
- 3
- Pages
- 172-186
- ISSN
- 1759-4812 (ISSN-L)
- 1759-4820
- OpenAlex
- W2899845148
- Cited by
- 64
- References
- 127
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 8 · 2023: 13 · 2022: 7 · 2021: 8 · 2020: 14 · 2019: 6 · 2018: 1
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Urology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Urology › Urological Disorders and Treatments
- Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
- Keywords
- Peyronie's disease, conservative treatment, oral therapy, topical treatment, intralesional therapy, collagenase clostridium histolyticum, mechanical treatment, penile curvature, penile deformity, patient counseling, sexual function
- MeSH terms
- Forecasting, Humans, Male, Penile Induration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nonsurgical management of Peyronie’s disease. https://app.cochat.ai/papers/10.1038/s41585-018-0117-7
- The paper
- Tsambarlis, P., & Levine, L. A. (2019). Nonsurgical management of Peyronie’s disease. Nature Reviews Urology. https://doi.org/10.1038/s41585-018-0117-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.